LB1101 Evaluating the Cardiovascular Safety of Low-Dose Oral Minoxidil in Patients with Non-Scarring Alopecia: A Retrospective Cohort Study

    July 2025 in “ Journal of Investigative Dermatology ”
    Christopher J Thang, Jeremiah Levine, David Gárate … Benjamin Ungar
    Studysummary Low-dose oral minoxidil is safe for the heart in the short term for hair loss patients.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on jidonline.org →
    Discuss this study in the Community →

    Related research 8

    1. Contact Dermatitis Caused by Topical Minoxidil: Allergy or Just Irritation Acta Dermato Venereologica · 2025
    2. Tolerance and Safety Profile of Sublingual Minoxidil in the Treatment of Androgenic Alopecia Actas Dermo-Sifiliográficas · 2024
    3. Efficacy and Safety of Low-Dose Oral Minoxidil in the Management of Androgenetic Alopecia Expert Opinion on Pharmacotherapy · 2024
    4. Minoxidil Sulfotransferase Enzymatical Activity in Plants: A Novel Paradigm in Increasing Minoxidil Response in Androgenetic Alopecia Journal of Cosmetic Dermatology · 2023
    5. Tretinoin Enhances Minoxidil Response in Androgenetic Alopecia Patients by Upregulating Follicular Sulfotransferase Enzymes Dermatologic Therapy · 2019
    6. The Use of Minoxidil in the Treatment of Male and Female Androgenetic Alopecia: A Story of More Than 30 Years Italian journal of dermatology and venereology · 2018
    7. A Randomized Clinical Trial of 5% Topical Minoxidil Versus 2% Topical Minoxidil and Placebo in the Treatment of Androgenetic Alopecia in Men Journal of The American Academy of Dermatology · 2002
    8. Androgenetic Alopecia: Treatment Results with Topical Minoxidil Journal of The American Academy of Dermatology · 1987